{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:37:27Z","timestamp":1779917847166,"version":"3.53.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":231,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Blair Foundation"},{"name":"Astra-Zeneca, Bayer Boehringer-Ingelheim"},{"DOI":"10.13039\/100002491","name":"Bristol-Myer-Squibb","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli-Lilly"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Janssen"},{"DOI":"10.13039\/100004339","name":"sanofi-aventis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jvsvs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JVS-Vascular Science"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.jvssci.2020.08.003","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T12:40:32Z","timestamp":1599050432000},"page":"168-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Fatty acid binding protein 3 is associated with peripheral arterial disease"],"prefix":"10.1016","volume":"1","author":[{"given":"Muzammil H.","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Zamzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Rotstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawand","family":"Abdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Qadura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvssci.2020.08.003_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jvssci.2020.08.003_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0031-1278244","article-title":"Peripheral arterial disease: epidemiology, natural history, diagnosis and treatment","volume":"16","author":"Dhaliwal","year":"2007","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jvssci.2020.08.003_bib3","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1161\/01.CIR.94.11.3026","article-title":"Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review","volume":"94","author":"Weitz","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jvssci.2020.08.003_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jvssci.2020.08.003_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.hlc.2017.10.014","article-title":"Peripheral arterial disease","volume":"27","author":"Conte","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jvssci.2020.08.003_bib6","first-page":"39","article-title":"Peripheral arterial disease: lack of awareness in Canada","volume":"25","author":"Lovell","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jvssci.2020.08.003_bib7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/CIA.S79355","article-title":"Multidisciplinary approach to the diagnosis and management of patients with peripheral arterial disease","volume":"10","author":"Walker","year":"2015","journal-title":"Clin Interv Aging"},{"issue":"3 Suppl","key":"10.1016\/j.jvssci.2020.08.003_bib8","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/j.jvs.2014.12.008","article-title":"A\u00a0systematic review for the screening for peripheral arterial disease in asymptomatic patients","volume":"61","author":"Alahdab","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvssci.2020.08.003_bib9","first-page":"CD010680","article-title":"Ankle brachial index for the diagnosis of lower limb peripheral arterial disease","volume":"9","author":"Crawford","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvssci.2020.08.003_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2296-15-69","article-title":"Current utility of the ankle-brachial index (ABI) in general practice: implications for its use in cardiovascular disease screening","volume":"15","author":"Davies","year":"2014","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.jvssci.2020.08.003_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3399\/bjgp09X420932","article-title":"Ankle brachial index measurement in primary care: are we doing it right?","volume":"59","author":"Nicolai","year":"2009","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jvssci.2020.08.003_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ejvs.2018.02.011","article-title":"Limited adherence to peripheral arterial disease guidelines and suboptimal ankle brachial index reliability in Dutch primary care","volume":"55","author":"Hageman","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvssci.2020.08.003_bib13","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvssci.2020.08.003_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.106.641936","article-title":"Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes","volume":"114","author":"O'Donoghue","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvssci.2020.08.003_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-5-3-170","article-title":"The human fatty acid-binding protein family: evolutionary divergences and functions","volume":"5","author":"Smathers","year":"2011","journal-title":"Hum Genomics"},{"key":"10.1016\/j.jvssci.2020.08.003_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacc.2012.08.1003","article-title":"The circulating level of FABP3 is an indirect biomarker of microRNA-1","volume":"61","author":"Varrone","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvssci.2020.08.003_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/bjsm.32.2.121","article-title":"Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein","volume":"32","author":"Sorichter","year":"1998","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jvssci.2020.08.003_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/kfv328","article-title":"Evaluation of the relative performance of drug-induced skeletal muscle injury biomarkers in rats","volume":"150","author":"Burch","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jvssci.2020.08.003_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/prca.200700006","article-title":"Quantification of heart fatty acid binding protein as a biomarker for drug-induced cardiac and musculoskeletal necroses","volume":"1","author":"Zhen","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jvssci.2020.08.003_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/toxsci\/kfn042","article-title":"Fabp3 as a biomarker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers","volume":"103","author":"Pritt","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jvssci.2020.08.003_bib21","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.jvs.2018.06.139","article-title":"Status of cardiac markers in patients with peripheral arterial disease and critical limb ischemia","volume":"68","author":"Jain","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvssci.2020.08.003_bib22","doi-asserted-by":"crossref","first-page":"e94834","DOI":"10.1371\/journal.pone.0094834","article-title":"Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study","volume":"9","author":"Otaki","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jvssci.2020.08.003_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1043-2760(00)00257-5","article-title":"The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function","volume":"11","author":"Hertzel","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"11 Suppl 1","key":"10.1016\/j.jvssci.2020.08.003_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0735-1097(20)30812-3","article-title":"The potential link between fatty acid-binding protein 3 and endothelial dysfunction","volume":"75","author":"Wu","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvssci.2020.08.003_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1073\/pnas.82.1.4","article-title":"Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes","volume":"82","author":"Stremmel","year":"1985","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.jvssci.2020.08.003_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jvssci.2020.08.003_bib27","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1152\/ajpendo.00475.2001","article-title":"Exercise training increases lipid metabolism gene expression in human skeletal muscle","volume":"283","author":"Tunstall","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jvssci.2020.08.003_bib28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/oby.21799","article-title":"Exercise training-induced improvement in skeletal muscle PGC-1alpha-mediated fat metabolism is independent of dietary glycemic index","volume":"25","author":"Mulya","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jvssci.2020.08.003_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1358836X0000500109","article-title":"Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease","volume":"5","author":"Brass","year":"2000","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvssci.2020.08.003_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1369\/0022155415569348","article-title":"Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function","volume":"63","author":"Koutakis","year":"2015","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.jvssci.2020.08.003_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1538574408315995","article-title":"The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type","volume":"42","author":"Pipinos","year":"2008","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jvssci.2020.08.003_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/1538574407311106","article-title":"The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction","volume":"41","author":"Pipinos","year":"2007","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jvssci.2020.08.003_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0741-5214(03)00602-5","article-title":"Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease","volume":"38","author":"Pipinos","year":"2003","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvssci.2020.08.003_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.freeradbiomed.2006.04.003","article-title":"Mitochondrial defects and oxidative damage in patients with peripheral arterial disease","volume":"41","author":"Pipinos","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jvssci.2020.08.003_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/1358863X07084858","article-title":"Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease","volume":"12","author":"Mitchell","year":"2007","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvssci.2020.08.003_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jcsm.12304","article-title":"Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies","volume":"9","author":"Spitali","year":"2018","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jvssci.2020.08.003_bib37","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["JVS-Vascular Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666350320300213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666350320300213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:13:10Z","timestamp":1762981990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666350320300213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":37,"alternative-id":["S2666350320300213"],"URL":"https:\/\/doi.org\/10.1016\/j.jvssci.2020.08.003","relation":{},"ISSN":["2666-3503"],"issn-type":[{"value":"2666-3503","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid binding protein 3 is associated with peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"JVS-Vascular Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvssci.2020.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}